Ballard v. Takeda Pharmaceuticals America, Inc., et al.

Annotate this Case

Download PDF

IN THE SUPREME COURT OF THE STATE OF DELAWARE ELISHA BALLARD, Plaintiff Below, Appellant, v. TAKEDA PHARMACEUTICALS AMERICA, INC., TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, and ELI LILLY AND COMPANY, Defendants Below, Appellees. § § § § § § § § § § § § § § § § § § § No. 361, 2017 Court Below: The Superior Court of the State of Delaware C.A. No. N16C-10-177 JRJ Submitted: April 18, 2018 Decided: April 23, 2018 Before STRINE, Chief Justice; SEITZ, and TRAYNOR, Justices. ORDER This 23rd day of April 2018, it appears to the Court that the judgment of the Superior Court should be affirmed on the basis of its opinion dated August 7, 2017.1 1 Ballard v. Takeda Pharm. Am., Inc., 2017 WL 3396488 (Del. Super. Ct. Aug. 7, 2017). NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior Court is hereby AFFIRMED. BY THE COURT: /s/ Leo E. Strine, Jr. Chief Justice 2

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.